322 related articles for article (PubMed ID: 22177089)
1. Fractalkine (CX3CL1) levels in patients with Behçet's disease and neuro-Behçet's disease.
Ceyla I; Tuba TK; Adisen E; Banu O; Isil F; Ali GM; Turgut I; Banu B
J Neurol Sci; 2012 Apr; 315(1-2):120-2. PubMed ID: 22177089
[TBL] [Abstract][Full Text] [Related]
2. Neuro-behçet's disease in South Korea: clinical characteristics and treatment response.
Yoon DL; Kim YJ; Koo BS; Kim YG; Lee CK; Yoo B
Int J Rheum Dis; 2014 May; 17(4):453-8. PubMed ID: 24506839
[TBL] [Abstract][Full Text] [Related]
3. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.
Houman MH; Bellakhal S; Ben Salem T; Hamzaoui A; Braham A; Lamloum M; Monia SK; Ben Ghorbel I
Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180
[TBL] [Abstract][Full Text] [Related]
5. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
Keskin D; Keskin G; Inal A; Ozışık L
Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging and proton magnetic resonance spectroscopy in neuro-Behçet's disease.
Park KS; Ko HJ; Yoon CH; Park SH; Cho CS; Kim HY; Choe BY; Kim WU
Clin Exp Rheumatol; 2004; 22(5):561-7. PubMed ID: 15485008
[TBL] [Abstract][Full Text] [Related]
7. Increased complexin-1 and decreased miR-185 expression levels in Behçet's disease with and without neurological involvement.
Uğurel E; Şehitoğlu E; Tüzün E; Kürtüncü M; Çoban A; Vural B
Neurol Sci; 2016 Mar; 37(3):411-6. PubMed ID: 26577184
[TBL] [Abstract][Full Text] [Related]
8. Increased serum interleukin-32 levels in patients with Behçet's disease.
Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
[TBL] [Abstract][Full Text] [Related]
9. The status of serum vitamin D in patients with active Behcet's disease compared with controls.
Khabbazi A; Rashtchizadeh N; Ghorbanihaghjo A; Hajialiloo M; Ghojazadeh M; Taei R; Kolahi S
Int J Rheum Dis; 2014 May; 17(4):430-4. PubMed ID: 24118939
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine: an activity marker in Behçet's disease?
Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impairment in Brazilian patients with Behçet's disease occurs independently of neurologic manifestation.
Dutra LA; de Souza AW; Alessi H; Guedes Bde V; Braga-Neto P; Pedroso JL; Gonçalves CR; da Rocha AJ; Bertolucci PH; Barsottini OG
J Neurol Sci; 2013 Apr; 327(1-2):1-5. PubMed ID: 23434335
[TBL] [Abstract][Full Text] [Related]
12. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
13. The expression of transmembrane and soluble CXCL16 and the relation with interferon-alpha secretion in patients with Behçet's disease.
Yilmaz S; Cinar M; Pekel A; Simsek I; Musabak U; Erdem H; Pay S
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):84-7. PubMed ID: 24064021
[TBL] [Abstract][Full Text] [Related]
14. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
[TBL] [Abstract][Full Text] [Related]
15. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
[TBL] [Abstract][Full Text] [Related]
16. Myocardial involvement in Behçet's disease may be higher in patients with Neuro-Behçet's disease: a speckle tracking echocardiographic study.
Sunbul M; Midi IG; Agackiran SK; Engin E; Ucem S; Alibaz-Oner F; Sayar N; Direskeneli H; Sadıc BO
Acta Cardiol; 2022 Aug; 77(6):515-523. PubMed ID: 34392811
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of GRO-α are elevated in association with disease activity in patients with Behçet's disease.
Kato Y; Yamamoto T
Int J Dermatol; 2012 Mar; 51(3):286-9. PubMed ID: 22348563
[TBL] [Abstract][Full Text] [Related]
18. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
19. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.
Duygulu F; Evereklioglu C; Calis M; Borlu M; Cekmen M; Ascioglu O
Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528
[TBL] [Abstract][Full Text] [Related]
20. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity.
Lee YJ; Kang SW; Song JK; Park JJ; Bae YD; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S41-5. PubMed ID: 17949550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
